title: [Interaction between active metabolites of vitamin D3 and blood aluminum in chronic uremic patients on dialysis].
abstract: In the present study, the authors show that 1, 25 (OH)2 D3 given to hemodialyzed patients taking Al (OH)3, increased their plasma concentrations of Al. Two mechanism can explain this increase: increased intestinal absorption or decreased tissue storage of Al.
authors.affiliation: Ambulatorio di Nefrologia e Dialisi Nefrodial, Avellino.
authors.forename: F
authors.initials: F
authors.lastname: Panico
authors.forename: A
authors.initials: A
authors.lastname: Salvati
authors.forename: F
authors.initials: F
authors.lastname: Scoppa
authors.forename: G F
authors.initials: GF
authors.lastname: Testa
authors.forename: A
authors.initials: A
authors.lastname: Capobianco
authors.forename: S
authors.initials: S
authors.lastname: Pacia
authors.forename: F
authors.initials: F
authors.lastname: Lauriello
authors.forename: A
authors.initials: A
authors.lastname: Aquino
authors.forename: V
authors.initials: V
authors.lastname: Tedesco
authors.forename: W
authors.initials: W
authors.lastname: Taccone
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000535:Aluminum / Q000494:pharmacology*; D000536:Aluminum Hydroxide / Q000493:pharmacokinetics / Q000627:therapeutic use; D002117:Calcitriol / Q000494:pharmacology* / Q000627:therapeutic use; D002908:Chronic Disease; D003676:Deferoxamine; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy / Q000209:etiology; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014018:Tissue Distribution; D014511:Uremia / Q000097:blood* / Q000150:complications / Q000628:therapy
chemical_list: D000536:Aluminum Hydroxide; D000535:Aluminum; D002117:Calcitriol; D003676:Deferoxamine
vernacular_title: Interazione tra metaboliti attivi della vitamina D3 ed alluminemia nell'uremico cronico in dialisi.